財務情報
- Market Capitalization 383.14 M
- Employee 231
- Founded 2005
- CEO Linda Marban
- Website www.capricor.com
- Headquarter Delaware, United States
- FIGI BBG000DZMK99
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-12.77
売上高対価格比率
—
関連ティッカー
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 3000 | SPRY ARS Pharmaceuticals, Inc. - Common Stock | 3.93 USD | -2.96% | -9.66% | -7.53% | -57.33% | 390.83 M USD | ||
| 3005 | DRUG Bright Minds Biosciences Inc. - common stock | 50.71 USD | -1.27% | -0.59% | -16.98% | -24.32% | 387.21 M USD | ||
| 3046 | AVIR Atea Pharmaceuticals, Inc. - common stock | 4.63 USD | -7.03% | -7.40% | -11.47% | +44.24% | 371.35 M USD | ||
| 3050 | GALT Galectin Therapeutics Inc. - Common Stock | 3.64 USD | -1.36% | +0.55% | -1.89% | -29.18% | 367.09 M USD |